Regulatory Guide: Exporting Japanese Cosmetics to the US, EU & ASEAN

Japan is one of the world's largest cosmetics exporters. According to Japan's Ministry of Finance, cosmetics exports exceeded ¥630 billion (approximately $4.3 billion) in 2024, more than tripling over the past decade. The top destination markets — China, Hong Kong, South Korea, the ASEAN bloc, the EU, and the United States — each impose their own distinct regulatory frameworks on imported cosmetics. For brand owners manufacturing in Japan through OEM partnerships, understanding these frameworks is not optional — it is a prerequisite for market access.

The regulatory environment for cosmetics varies dramatically from one market to another. What Japan classifies as a "cosmetic" may be regulated as a "drug" or "special cosmetic" elsewhere. An ingredient permitted in Japan at a given concentration may be restricted or outright banned in the EU. A labeling format that satisfies the US FDA may be wholly non-compliant in Thailand. These differences are not merely bureaucratic inconveniences — a single compliance failure can result in shipment seizure at customs, product recalls, market bans, and reputational damage that undermines years of brand building.

This guide provides a market-by-market regulatory breakdown for the four most important export destinations for Japanese cosmetics: the United States, the European Union, China, and the ASEAN bloc. For each market, we cover the governing legislation, product classification, registration or notification requirements, labeling rules, and ingredient restrictions. We then address cross-cutting topics including documentation, ingredient compliance across multiple markets, common compliance mistakes, and how to work with regulatory consultants to streamline the export process.

Whether you are an established brand expanding into new territories or a startup launching your first product line through a Japanese OEM manufacturer, this guide will help you build a regulatory strategy that avoids costly surprises and accelerates your time to market.

The United States is a high-value market for Japanese cosmetics, with growing consumer awareness of J-Beauty driven by social media, K-Beauty crossover interest, and the premiumization trend in skincare. However, the US regulatory framework — governed primarily by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and administered by the Food and Drug Administration (FDA) — differs substantially from Japan's Pharmaceutical and Medical Device Act (PMD Act).

Regulatory Classification

The FDA defines cosmetics as "articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance." Critically, products that claim to affect the structure or function of the body — such as anti-aging, anti-acne, or skin-lightening claims — may be classified as drugs under US law, requiring pre-market approval through the New Drug Application (NDA) process or compliance with an applicable OTC Drug Monograph. This is a major divergence from Japan, where such products may fall under the "quasi-drug" category, which has a regulatory pathway distinct from both cosmetics and pharmaceuticals.

The Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022 and with major provisions taking effect in 2024–2025, represents the most significant overhaul of US cosmetics regulation in decades. Key MoCRA provisions include:

• Facility registration: Cosmetics manufacturing and processing facilities (including foreign facilities like Japanese OEM plants) must register with the FDA.
• Product listing: Each cosmetic product distributed in the US must be listed with the FDA, including its ingredients and labeling.
• Adverse event reporting: Serious adverse events must be reported to the FDA within 15 business days.
• Good Manufacturing Practice (GMP): The FDA is developing mandatory GMP requirements for cosmetics facilities, expected to align closely with ISO 22716.
• Safety substantiation: Companies must have adequate evidence of safety for each product and ingredient.

Labeling Requirements

FDA cosmetics labeling requirements are precise and failure to comply is one of the most common reasons imported cosmetics are detained at US customs. Key requirements include:

• Principal Display Panel (PDP): Must include the product identity (what it is), net quantity of contents (in both metric and US customary units), and any required warnings.
• Information Panel: Must include the name and address of the manufacturer, packer, or distributor; ingredient declaration in descending order of predominance using INCI nomenclature; directions for use (if applicable); and warning statements.
• Language: All required information must appear in English. Bilingual labeling (English plus Japanese or other languages) is permitted but English is mandatory.
• Font size: The ingredient declaration must be in type no less than 1/16 inch (1.6 mm) in height, or if the total package area is less than 12 square inches, no less than 1/32 inch (0.8 mm).
• Color additive declaration: Color additives must be listed by their FDA-designated names (e.g., "Red 7 Lake") rather than INCI names or CI numbers alone.

Prohibited and Restricted Ingredients

The US has historically had a relatively short list of prohibited cosmetic ingredients compared to the EU (approximately 11 prohibited substances versus the EU's 1,600+). However, MoCRA has expanded the FDA's authority to ban or restrict ingredients. Key restrictions relevant to Japanese cosmetics exports include:

• Mercury compounds: Banned except as preservatives in eye cosmetics at concentrations up to 65 ppm (though this exception is rarely used in modern formulations).
• Chloroform and methylene chloride: Prohibited as cosmetic ingredients.
• PFAS (per- and polyfluoroalkyl substances): Increasing regulatory scrutiny. Several US states have enacted or proposed bans on intentionally added PFAS in cosmetics, and federal action is expected.
• Certain UV filters: Some UV filters approved in Japan and the EU (such as Tinosorb S and Tinosorb M) are not approved by the FDA for use in OTC sunscreens. Products containing unapproved UV filters cannot be marketed as sunscreens in the US. This is a critical formulation consideration when developing products for multi-market distribution.
• Formaldehyde and formaldehyde-releasing preservatives: While not federally banned, several states (notably California) restrict these, and the MoCRA framework is expected to address them at the federal level.

Practical Considerations for Japanese Exporters

When exporting Japanese-made cosmetics to the US, work with your OEM manufacturer to ensure the formulation avoids ingredients that straddle the cosmetic/drug line in US classification. Sunscreen products are a particular pain point — in Japan, sunscreens are classified as quasi-drugs; in the US, they are OTC drugs subject to a different regulatory regime. If your product line includes sunscreens, you will likely need a US-specific formulation. Your Japanese OEM partner should also be prepared to register their facility with the FDA under MoCRA requirements and to support product listing submissions.

The European Union has the most comprehensive and prescriptive cosmetics regulatory framework in the world. Regulation (EC) No 1223/2009 — commonly referred to as the EU Cosmetics Regulation — governs the manufacture, import, distribution, and sale of all cosmetic products within the 27 EU member states plus the EEA countries (Norway, Iceland, Liechtenstein). It is widely considered the global gold standard for cosmetics regulation, and many other jurisdictions (including ASEAN and several Middle Eastern countries) have modeled their frameworks on it.

Key Requirements Under EC 1223/2009

1. Responsible Person (RP)

Every cosmetic product placed on the EU market must have a designated Responsible Person established within the EU/EEA. The RP bears legal responsibility for product safety and regulatory compliance. For Japanese exporters, this means you must either:

• Establish a legal entity within the EU, or
• Appoint an EU-based importer or distributor as your Responsible Person, or
• Contract a third-party Responsible Person service provider (the most common approach for foreign brands entering the EU).

The RP's name and address must appear on the product label. The RP is responsible for ensuring that the product complies with all provisions of EC 1223/2009, including maintaining the Product Information File, reporting serious undesirable effects to competent authorities, and cooperating with market surveillance authorities.

2. Cosmetic Product Notification Portal (CPNP)

Before a cosmetic product is placed on the EU market, the Responsible Person must submit a notification through the CPNP. The notification includes the product category, product name, the Responsible Person's identity, the country of origin (Japan), the member state(s) where the product will be marketed, contact information, the product's frame formulation, and the original label. CPNP notification is free of charge but must be completed before the first unit is sold.

3. Product Information File (PIF)

The RP must maintain a comprehensive PIF for each product, available for inspection by competent authorities. The PIF must include:

• A description of the cosmetic product sufficient to clearly relate the PIF to the product.
• The Cosmetic Product Safety Report (CPSR), consisting of Part A (safety information: quantitative/qualitative composition, physical/chemical characteristics, microbiological quality, impurities, packaging, normal/reasonably foreseeable use, exposure, toxicological profiles, undesirable effects, and relevant information on the product) and Part B (the safety assessment conclusion by a qualified Safety Assessor).
• Description of the manufacturing method and a statement of compliance with GMP (ISO 22716).
• Proof of the claimed effect (where claims are made).
• Data on animal testing performed in relation to the development or safety assessment of the product or its ingredients.

4. Safety Assessment

The safety assessment must be performed by a person holding a university-level qualification in pharmacy, toxicology, medicine, or a similar discipline. This individual — the Safety Assessor — evaluates all toxicological and exposure data and issues a formal opinion on whether the product is safe for human health under normal or reasonably foreseeable conditions of use. The Safety Assessor must be independent and qualified, and their assessment forms Part B of the CPSR. Most Japanese exporters engage a European regulatory consultancy that has qualified Safety Assessors on staff or in their network.

Ingredient Restrictions

The EU maintains the world's most extensive list of restricted and prohibited cosmetics ingredients:

• Annex II: Over 1,600 substances prohibited in cosmetic products.
• Annex III: Substances restricted to specific concentration limits, product types, or usage conditions (e.g., certain hair dyes, UV filters, preservatives, and colorants).
• Annex IV–VI: Positive lists for colorants, preservatives, and UV filters — only substances on these lists may be used for those functions.

For Japanese manufacturers, several commonly used ingredients in the Japanese market require careful attention for EU compliance:

• Certain preservatives: Methylisothiazolinone (MI) is banned in EU leave-on products (restricted to rinse-off products at 0.0015%). Some Japanese formulations still use MI in leave-on products.
• UV filters: Certain UV filters approved in Japan (e.g., some benzotriazole-type filters) may not be listed on the EU Annex VI positive list. Only UV filters included in Annex VI may be used for sun-protection purposes in the EU.
• Nanomaterials: Any ingredient present as a nanomaterial must be indicated in the ingredients list with "(nano)" after the ingredient name. The EU has specific notification and safety assessment requirements for nanomaterials.
• CMR substances: Substances classified as Carcinogenic, Mutagenic, or Toxic to reproduction (Category 1A, 1B, or 2) under the CLP Regulation are generally prohibited in cosmetics unless specifically exempted.

Labeling Requirements

EU cosmetic product labels must include: the name and address of the Responsible Person; the nominal content at time of packaging (in weight or volume); the date of minimum durability ("best before") or, if durability exceeds 30 months, the Period After Opening (PAO) symbol with the number of months; particular precautions for use; the batch number; the product function (unless obvious from presentation); the list of ingredients (preceded by the word "Ingredients"); and the country of origin for products manufactured outside the EU (i.e., "Made in Japan"). Labeling must be in the official language(s) of the member state where the product is sold. For multi-market distribution, brands typically use multi-language labels or country-specific back labels.

Animal Testing Ban

The EU maintains a complete ban on animal testing for cosmetics, covering both finished products and ingredients. Products or ingredients tested on animals after the relevant cutoff dates cannot be placed on the EU market, regardless of where the testing took place. Japan does not require animal testing for cosmetics, so Japanese-manufactured products are generally compliant, but you must be able to provide documentation confirming no animal testing was performed.

China represents the single largest export market for Japanese cosmetics by value, yet it also presents one of the most complex regulatory environments. The National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), regulates all cosmetics imported into mainland China under the Cosmetics Supervision and Administration Regulation (CSAR), which took effect on January 1, 2021, replacing the 1989-era regulations.

Product Classification

China classifies cosmetics into two categories:

• Special cosmetics: Products used for hair dyeing, hair perming, spot removal/whitening, sun protection, and anti-hair-loss. These require full NMPA registration, which involves a comprehensive review process including formula review, safety testing, and potentially human efficacy testing.
• General cosmetics: All other cosmetics, including skincare (excluding whitening), makeup, fragrance, hair care (excluding dyes and perms), and nail products. Since the 2021 CSAR reform, general cosmetics require only filing (bei'an) rather than full registration — a significantly simplified process.

Registration and Filing Process

General cosmetics filing (bei'an): The filing process for imported general cosmetics is handled through an authorized Chinese agent (the "Domestic Responsible Person" or DRP). The timeline has been reduced to approximately 3–5 months from submission to approval under the new CSAR framework. Required documents include the product formula, safety assessment report, quality specification, production process description, product labels, and evidence supporting any claims made.

Special cosmetics registration: Special cosmetics still require full NMPA registration, which takes approximately 12–18 months. The registration process involves product testing at NMPA-designated laboratories in China, including safety testing (skin irritation, eye irritation, skin allergy, etc.), human efficacy testing (for sunscreen SPF/PA values, whitening efficacy, anti-hair-loss efficacy), and stability testing. The product must be tested in its final packaging, meaning your product and packaging must be finalized before the registration process begins.

The Animal Testing Question

China's animal testing requirements have undergone significant reform in recent years:

• Pre-2021 regime: All imported cosmetics were subject to mandatory animal testing as part of the safety evaluation process. This was a major barrier for cruelty-free brands.
• Post-2021 CSAR reform: For general cosmetics imported into China, animal testing is no longer mandatory if the product manufacturer's facility meets specific conditions — notably, the manufacturing facility must hold GMP certification (ISO 22716 or equivalent) from a recognized authority, and the brand must submit a product safety assessment report that meets Chinese standards. This reform opened the Chinese market to many cruelty-free brands for the first time.
• Remaining exceptions: Special cosmetics (sunscreens, whitening products, hair dyes, etc.) may still be subject to animal testing during the NMPA registration process, particularly for efficacy testing. Additionally, post-market surveillance testing may involve animal testing if safety concerns arise.

For Japanese OEM manufacturers with ISO 22716 certification, the post-2021 framework offers a viable pathway to the Chinese market without animal testing for most product categories. However, the regulatory landscape continues to evolve, and it is essential to work with a knowledgeable Chinese regulatory agent who monitors NMPA guidance updates.

Labeling Requirements for China

Chinese labeling requirements include: all mandatory information must be in simplified Chinese; the Chinese product name (which may be a transliteration, translation, or a distinct name); the name and address of the Domestic Responsible Person and the original manufacturer; the net content; the full ingredient list using INCI names with Chinese translations; the production date and expiration date (or shelf life); the production license number or filing number; the product usage and precautions; and an import commodity inspection mark. Brands typically apply Chinese-language labels as a sticker or sleeve over the original Japanese packaging.

Practical Considerations

Brands planning to enter the China market should factor the NMPA filing or registration timeline into their product development schedule. Many brands use Hong Kong, Macau, or cross-border e-commerce (CBEC) channels as interim market entry strategies while NMPA registration is pending. CBEC platforms like Tmall Global and JD Worldwide allow the sale of imported cosmetics without NMPA registration, though volumes are capped and the regulatory treatment of CBEC products may tighten over time. A dual-track strategy — CBEC for immediate sales and NMPA filing for long-term general trade access — is a common approach.

The ten-member Association of Southeast Asian Nations (ASEAN) — Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam — collectively represents one of the fastest-growing cosmetics markets in the world. The region's combined cosmetics market was valued at approximately $30 billion in 2024, with annual growth rates of 7–10%. For Japanese cosmetics exporters, ASEAN offers attractive demographics, strong affinity for Japanese brands, and a harmonized regulatory framework that simplifies multi-country market entry.

The ASEAN Cosmetic Directive (ACD)

The ASEAN Cosmetic Directive, modeled on the EU Cosmetics Directive (and subsequently updated to align with the EU Cosmetics Regulation), provides a harmonized regulatory framework across all 10 member states. The ACD covers product definition, safety requirements, labeling, and ingredient restrictions (including positive lists for colorants, preservatives, UV filters, and a negative list of prohibited substances that largely mirrors the EU's).

Under the ACD, a cosmetic product is defined as any substance or preparation intended to be placed in contact with external parts of the human body or with the teeth and mucous membranes of the oral cavity, with a view to cleaning, perfuming, changing appearance, protecting, keeping in good condition, or correcting body odors. Products that claim to treat, cure, or prevent disease are classified as pharmaceuticals and fall outside the ACD scope.

Product Notification System

The ASEAN Cosmetic Directive requires pre-market product notification (not registration or approval) in each member state where the product will be sold. The notification is submitted by the company responsible for placing the product on the market in that country — typically a local distributor, importer, or the brand's subsidiary. Each ASEAN member state has its own notification portal and process:

• Thailand (FDA Thailand): Uses the e-Submission system. Thailand has one of the most well-established notification processes in ASEAN, typically completed within 3–5 business days for standard products.
• Indonesia (BPOM): Requires notification through the BPOM e-service system. Processing times are typically 2–4 weeks. Indonesia has additional domestic requirements, including Halal certification for cosmetics starting from October 2026.
• Malaysia (NPRA): Uses the QUEST3+ online system. Notification is typically processed within 1–3 weeks.
• Philippines (FDA Philippines): Requires a Certificate of Product Notification (CPN). Processing takes approximately 2–4 weeks.
• Singapore (HSA): Uses the PRISM e-system. Singapore has a notification-only regime with minimal documentation requirements and rapid processing (typically 1–5 business days).
• Vietnam (DAV): Requires product notification and receipt of a Product Notification Number (PNN) before market placement. Processing takes 2–3 weeks.

Mutual Recognition Arrangement (MRA)

The ASEAN Mutual Recognition Arrangement for Cosmetic Products facilitates trade within the region by establishing harmonized technical requirements for GMP, product safety, labeling, and ingredient standards. While a product notification obtained in one ASEAN country does not automatically grant market access in another, the harmonized regulatory framework means that a product formulated to comply with the ACD can generally be notified in all member states without reformulation. The key practical benefit for Japanese exporters is that you can develop a single ASEAN-compliant formulation and then notify it sequentially across multiple ASEAN markets, using the same core documentation.

Ingredient Restrictions

ASEAN ingredient restrictions are closely aligned with the EU framework. The ASEAN Cosmetic Directive maintains its own lists of prohibited substances, restricted substances, positive lists for UV filters, preservatives, and colorants, which are periodically updated to align with EU Annexes. However, implementation and enforcement intensity vary by member state — Indonesia and Thailand tend to have the most rigorous enforcement, while some newer ASEAN members may have less developed inspection infrastructure.

Labeling Requirements

The ACD specifies minimum labeling requirements including: product name; intended use; ingredients list (using INCI nomenclature); name and address of manufacturer/importer; country of origin; batch number; manufacturing and expiration dates; net content; precautions; and directions for use. Individual member states may impose additional language requirements — labels in Thailand must include Thai, labels in Indonesia must include Bahasa Indonesia, and so on. Many Japanese exporters produce ASEAN-market labels in the relevant local language(s) plus English.

Successful cosmetics export depends not only on a compliant formulation but also on a complete documentation package. Your Japanese OEM manufacturing partner should be able to provide or assist with the following documents. We recommend compiling a master export documentation file for each SKU and keeping it updated with every formulation revision or regulatory change.

Core Documents (Required for All Markets)

• Certificate of Free Sale (CFS): Issued by a Japanese Chamber of Commerce and Industry (JCCI) or prefectural government, confirming that the product is legally manufactured and freely sold in Japan. Most destination countries require a CFS that is notarized, apostilled, or legalized by the destination country's embassy in Japan. The CFS must list the product name, manufacturer name, and manufacturing address.
• Certificate of Analysis (CoA): A batch-specific quality certificate issued by the manufacturer's quality control laboratory. The CoA typically includes microbial testing results (total aerobic count, yeast and mold, specific pathogens), heavy metals content (lead, arsenic, mercury, cadmium), pH, viscosity, appearance, and active ingredient assay values. Some markets (particularly China and certain ASEAN countries) require CoAs from third-party accredited laboratories in addition to the manufacturer's in-house CoA.
• Good Manufacturing Practice (GMP) Certificate: Proof that the manufacturing facility operates in accordance with ISO 22716 (Cosmetics — Good Manufacturing Practices). This is required for EU market entry, is necessary for the China animal testing exemption pathway, and is increasingly expected by regulatory authorities and retail partners worldwide. Japanese OEM facilities certified to ISO 22716 should be able to provide a copy of their certificate from the certifying body.
• Full Ingredient List: A complete quantitative formula listing all ingredients by INCI name, CAS number, and concentration (typically expressed as weight percentage). This document is confidential and shared only with regulatory authorities and Safety Assessors, not placed on the product label.
• Material Safety Data Sheets (MSDS/SDS): Required for customs clearance and logistics compliance. Each cosmetic product should have an MSDS covering its physical and chemical properties, hazard identification, handling and storage requirements, and first aid measures. Products containing ethanol, volatile solvents, or aerosol propellants may be classified as dangerous goods for transportation purposes.

EU-Specific Documents

• Product Information File (PIF): The comprehensive dossier maintained by the Responsible Person (see EU section above).
• Cosmetic Product Safety Report (CPSR): The formal safety assessment document, prepared and signed by a qualified Safety Assessor, that forms part of the PIF.
• CPNP notification receipt: Confirmation that the product has been notified through the Cosmetic Products Notification Portal.
• Manufacturing process description: A detailed description of the manufacturing method, including equipment used, batch size, process parameters, and in-process controls.
• Stability data: Stability study reports demonstrating the product remains within specification throughout its shelf life under defined storage conditions.
• Claims evidence: Supporting data for any claims made on the label or in marketing materials, in compliance with the EU Claims Regulation (EC No 655/2013).

US-Specific Documents

• FDA Facility Registration confirmation: Under MoCRA, the manufacturing facility must be registered with the FDA. The confirmation of registration should be maintained on file.
• FDA Product Listing confirmation: Each product must be listed with the FDA, and the listing confirmation should be retained.
• Safety substantiation documentation: Evidence supporting the safety of the product and its ingredients, as required by MoCRA.

China-Specific Documents

• NMPA filing or registration certificate: The approval document issued by NMPA for the specific product.
• Chinese-language product label artwork: Approved by the NMPA as part of the filing or registration process.
• Authorized Chinese agent (DRP) agreement: Documentation of the contractual relationship with the Domestic Responsible Person who handles regulatory filings on your behalf in China.
• Product safety assessment report: Prepared in accordance with Chinese Technical Safety Standards for Cosmetics (2015 edition, as amended).

One of the most challenging aspects of multi-market cosmetics export is navigating the differences in ingredient regulations across jurisdictions. An ingredient that is freely permitted in Japan may be restricted, conditionally permitted, or outright banned in another market. Below is an overview of the most significant areas of divergence that Japanese OEM manufacturers and their brand clients must address when formulating products for international distribution.

UV Filters

UV filters are perhaps the single most problematic ingredient category for multi-market compliance:

• Japan: Has a positive list of approved UV filters under the PMD Act quasi-drug regulations. Japan approves many UV filters that are widely used in Asian and European markets.
• EU: Maintains a positive list (Annex VI) of approved UV filters. Many modern organic UV filters (e.g., Tinosorb S, Tinosorb M, Mexoryl SX, Mexoryl XL) are approved in the EU.
• US: Has the most restrictive UV filter regime among major markets. Only 16 UV filters are approved for OTC sunscreen use, and no new UV filter has been approved in over two decades. Newer-generation organic filters widely used in Japan and Europe (Tinosorb, Mexoryl, Uvinul A Plus) are not approved in the US. This often requires a completely separate US formulation relying on zinc oxide, titanium dioxide, and the limited approved organic filters.
• ASEAN: Generally follows the EU positive list with minor variations. Most UV filters approved in the EU are also permitted in ASEAN countries.
• China: Has its own positive list, which overlaps significantly but not completely with the EU list.

Preservatives

• Parabens: Permitted in all major markets but with varying concentration limits. The EU restricts the total concentration of propylparaben and butylparaben to 0.14% (as acid). Japan and the US permit higher concentrations.
• Methylisothiazolinone (MI): Banned in EU leave-on cosmetics since 2016; restricted to rinse-off products at 0.0015%. Still permitted in some other markets but increasingly avoided globally due to sensitization concerns.
• Phenoxyethanol: Permitted in all markets, generally at 1.0% maximum. One of the most universally accepted preservatives for multi-market formulations.
• Formaldehyde donors: Increasingly restricted. The EU has banned formaldehyde itself in cosmetics and restricts formaldehyde-releasing preservatives with mandatory labeling when free formaldehyde exceeds 0.05%. California in the US has similar restrictions. Japanese regulations are less restrictive in this area.

Colorants

Color additive regulations differ significantly:

• The EU maintains a positive list of permitted colorants in Annex IV of EC 1223/2009.
• The US FDA has its own batch-certification system for certain color additives (FD&C colors) and restricts the use of colorants based on product type (eye area, lip area, externally applied).
• A colorant approved in Japan may not be listed on the EU or US positive lists, and vice versa. When formulating sheet masks or makeup products for multi-market distribution, the ingredient list must be cross-checked against each destination market's colorant regulations.

Fragrance Allergens

The EU requires mandatory declaration of 26 allergenic fragrance substances (such as linalool, limonene, citronellol, geraniol) on the ingredient label when their concentration exceeds specified thresholds (0.001% in leave-on products, 0.01% in rinse-off products). As of 2024, this list has been expanded to include additional allergens. Japan and the US do not currently require individual fragrance allergen declaration — fragrances can be listed simply as "Fragrance" or "Parfum." However, products destined for the EU must declare these substances individually on the label, which your OEM manufacturer's perfumer must take into account during formulation.

Developing Multi-Market Formulations

The most cost-effective approach is to develop a "highest-common-denominator" formulation that complies with the most restrictive regulations across all target markets simultaneously. For most ingredient categories, this means formulating to EU standards (the most restrictive) while also avoiding UV filters not approved in the US (if the US is a target market). Your Japanese OEM partner's regulatory affairs team should be involved from the earliest stages of product development to flag potential compliance issues before formulation is finalized. Reformulating after production has begun is exponentially more expensive than designing for multi-market compliance from the start.

Even experienced brands encounter regulatory pitfalls when exporting cosmetics from Japan. Based on patterns observed across the industry, the following are the most common compliance mistakes — and how to avoid them.

1. Assuming Japanese Compliance Equals Global Compliance

This is the single most dangerous assumption in cosmetics export. A product that is fully compliant under Japan's PMD Act may contain ingredients prohibited in the EU, use UV filters not approved in the US, or make claims that trigger a different regulatory classification in China. Every target market's regulations must be independently verified against your formula and labeling before export. Do not rely on the fact that your product is legally sold in Japan as evidence of compliance elsewhere.

2. Incorrect Labeling Language or Format

Labeling non-compliance is the most frequent cause of cosmetics shipments being detained at customs. Common errors include:

• Failing to include mandatory information in the local language (e.g., Chinese for China, Thai for Thailand, the official language(s) of the EU member state).
• Using Japanese-format dates (YYYY.MM.DD or the Japanese era calendar) instead of the destination market's required format.
• Omitting the Responsible Person's name and address on EU-destined products.
• Using INCI names or CI numbers for color additives in the US instead of the FDA-mandated color additive names.
• Listing "Fragrance" as a single entry on EU-destined products without declaring individual fragrance allergens above threshold concentrations.
• Printing net contents only in metric units for the US market (both metric and US customary units are required).

3. Underestimating China NMPA Timelines

Brands frequently plan a China market entry with optimistic timelines that do not account for the full NMPA filing or registration process. For general cosmetics, the filing process takes 3–5 months at minimum. For special cosmetics (sunscreens, whitening products), registration can take 12–18 months and requires product testing at NMPA-designated Chinese laboratories — meaning physical samples must be shipped to China well in advance. Failing to plan for these timelines results in missed launch dates, wasted marketing spend, and retailer frustration.

4. Neglecting the EU Responsible Person Requirement

Some brands attempt to sell into the EU without properly appointing a Responsible Person, either by listing a non-EU address on the label or by relying on an informal arrangement with a distributor who does not understand the legal obligations of the RP role. This is a compliance violation that can result in product withdrawal from the market and penalties. The RP must be formally appointed, genuinely established in the EU/EEA, and must maintain the complete Product Information File.

5. Making Drug Claims on Cosmetic Products

Claim compliance is a nuanced area where Japanese and international regulations diverge significantly. Japan's quasi-drug category allows certain efficacy claims (whitening, anti-wrinkle, anti-acne) under a regulated framework. In the US, these same claims may cause a product to be classified as a drug. In the EU, claims must comply with the Common Criteria for cosmetic product claims (Regulation EC 655/2013) and cannot imply therapeutic effects. Marketing materials developed for the Japanese market must be thoroughly reviewed and adapted for each export market to avoid regulatory classification issues.

6. Ignoring Post-Market Obligations

Regulatory compliance does not end at the point of sale. Most major markets have post-market surveillance obligations including adverse event reporting (mandatory in the US under MoCRA and in the EU under EC 1223/2009), product recall procedures, and ongoing monitoring of regulatory updates that may affect your product's compliance status. Establishing these post-market monitoring systems before launch — not after the first incident — is essential.

7. Failing to Account for Reformulation Costs

When a compliance issue is discovered after production, the cost of reformulation, re-testing, re-packaging, and re-notification can be 5–10 times the cost of building compliance into the original formulation. Always conduct a comprehensive multi-market regulatory review at the formulation development stage, not after bulk production is complete.

Given the complexity and market-specific nature of cosmetics regulations, most brands exporting Japanese-made cosmetics engage specialized regulatory consultants to manage compliance across their target markets. Here is how to evaluate, select, and work effectively with regulatory service providers.

When You Need a Regulatory Consultant

You should engage a regulatory consultant when:

• You are entering a new market for the first time and lack in-house knowledge of that market's regulations.
• Your product line includes categories with complex regulatory requirements (sunscreens, quasi-drugs, products with medical-sounding claims).
• You need to appoint an EU Responsible Person or a China Domestic Responsible Person.
• You need to compile a Product Information File and Commission a Safety Assessment for the EU.
• You need to manage NMPA registration or filing for the China market.
• You need to coordinate simultaneous notification across multiple ASEAN countries.
• Your formulation uses ingredients that may have different regulatory statuses across markets.

Types of Regulatory Service Providers

Full-service regulatory consultancies: These firms offer end-to-end regulatory support including formulation review, ingredient compliance screening, safety assessment, documentation preparation, product notification or registration, labeling review, and post-market surveillance. Major global firms include Delphic HSE, RIGPA, Obelis, and Intertek Regulatory Services. Regional specialists include firms focused on EU (e.g., BioVendis, CG Regulatory), China (e.g., CIRS, ChemLinked), and ASEAN (e.g., CARE Laboratories, Product Life Group).

Responsible Person service providers: Companies that specifically offer Responsible Person services for the EU market, taking on the legal obligations of the RP including PIF maintenance, CPNP notification, and adverse event reporting. These are often regulatory consultancies that also offer RP services, or specialized RP-only firms.

Testing laboratories: Accredited laboratories that perform the specific tests required by destination market regulations, including safety testing (dermal irritation, ocular irritation, sensitization, genotoxicity), stability testing, preservative efficacy testing, SPF and UVA testing, and microbiological testing. Selecting a laboratory with accreditation recognized by your target market's regulatory authority is essential.

Japanese OEM regulatory teams: Many established Japanese OEM manufacturers have in-house regulatory affairs departments with experience supporting international clients. While these teams can handle much of the formulation compliance work and documentation preparation, they typically partner with market-specific consultancies for EU RP services, China NMPA filing, and local-language labeling review.

Selecting the Right Consultant

When evaluating regulatory consultants, consider the following criteria:

• Market-specific expertise: Ensure the consultant has demonstrated experience with your specific target markets. A consultant expert in EU regulations may not have the depth of knowledge needed for China NMPA filing.
• Product category experience: Cosmetics regulation can vary significantly by product category. A consultant experienced with skincare products may lack expertise in hair dye regulation or aerosol products.
• Language capabilities: The consultant should be able to communicate effectively with your team, your Japanese OEM manufacturer, and the destination market's regulatory authorities.
• Turnaround times: Regulatory review and documentation preparation timelines can vary significantly between providers. Establish clear timeline expectations upfront.
• References: Ask for references from other Japanese or Asian cosmetics brands the consultant has supported in your target markets.
• Cost structure: Regulatory consulting fees vary widely. EU safety assessments typically cost EUR 1,500–5,000 per product. China NMPA filing services range from RMB 30,000–80,000 per product. ASEAN notification services range from $500–2,000 per country per product. Ensure you understand the full cost scope before engaging.

Integrating Regulatory Consultants into Your Workflow

The most effective approach is to involve your regulatory consultant at the formulation development stage, not after the product is finalized. This allows the consultant to screen your proposed ingredient list against all target market regulations before your OEM manufacturer invests time in formulation optimization. A typical integrated workflow looks like this:

1. Pre-formulation regulatory screening: Consultant reviews the proposed ingredient list and product concept against all target market regulations. Flags any ingredients that are restricted, banned, or require special handling in any destination market.
2. Formulation development: OEM manufacturer develops the formulation within the regulatory guardrails established in step 1.
3. Labeling and claims review: Consultant reviews proposed labeling and marketing claims for compliance in all target markets.
4. Documentation compilation: Consultant prepares market-specific documentation (PIF for EU, NMPA filing dossier for China, notification documents for ASEAN) using data provided by the OEM manufacturer.
5. Testing coordination: Consultant coordinates any market-specific testing requirements (e.g., SPF testing at an EU-recognized laboratory, human safety testing at an NMPA-designated laboratory in China).
6. Submission and follow-up: Consultant submits notification, filing, or registration applications and manages any queries or requests for additional information from regulatory authorities.
7. Post-market monitoring: Consultant monitors regulatory changes in target markets and advises on any compliance updates needed.

By structuring your regulatory workflow this way, you minimize the risk of costly reformulation, avoid launch delays caused by compliance gaps, and build a robust regulatory foundation that supports long-term international expansion. Platforms like OEM JAPAN can help you connect with Japanese OEM manufacturers experienced in multi-market export, many of whom have established relationships with regulatory consultancies across key destination markets.